Lidbree

Lidocaine, the active ingredient in Lidbree, is a local anesthetic presented as a formulation for intrauterine use. It provides targeted numbness to the uterine lining during procedures and is used in women undergoing gynecologic interventions. GNH USA supplies Lidbree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidbree is a local anesthetic that acts on the uterine mucosa to reduce procedural pain. - Hysteroscopic procedures: provides local anesthesia to minimize discomfort during diagnostic or operative hysteroscopy. - Intrauterine device (IUD) insertion: numbs the uterine cavity to facilitate painless placement of an IUD. - Uterine curettage: offers pain control during suction or sharp curettage of the endometrium.

Lidbree may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Uterine cramping: mild to moderate contractions after administration. - Vaginal spotting or bleeding: transient post‑procedure discharge. - Nausea: occasional feeling of queasiness. - Headache: mild tension‑type headache. - Dizziness: brief light‑headedness. - Local irritation: burning or stinging at the application site.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Cardiovascular toxicity: arrhythmias, hypotension, or cardiac arrest. - Central nervous system toxicity: seizures or severe confusion. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Severe uterine perforation: rare but serious complication. - Persistent severe pain: may indicate inadequate anesthesia or complication.

When using Lidbree, clinicians should observe the following precautions. - Allergy assessment: confirm no known hypersensitivity to lidocaine or amide‑type anesthetics. - Cardiovascular status: evaluate for existing arrhythmias or heart block before administration. - Dosage limits: adhere to recommended intrauterine concentrations to avoid systemic toxicity. - Pregnancy considerations: use only when benefit outweighs potential risk to the fetus. - Concomitant CNS depressants: monitor patients receiving other agents that may potentiate sedation. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Lidbree can interact with other medicines that affect cardiac conduction or metabolism.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): additive cardiac toxicity. - Amiodarone: may increase lidocaine plasma levels and risk of toxicity. - Cimetidine: reduces hepatic clearance, raising systemic exposure.

Moderate Interactions (Monitor Closely): - Epinephrine: can increase systemic absorption, requiring dose adjustment. - Other local anesthetics: cumulative toxicity risk if used concurrently. - Alcohol: enhances central nervous system depression. - CYP3A4 inhibitors (e.g., ketoconazole): may modestly raise lidocaine levels.